Translational research is a lengthy, complex, and necessary endeavor in order to bring basic science discoveries to clinical fruition. The NIH offers several programs to support translational research including an important resource established specifically for gene therapy researchers—the National Heart, Lung, and Blood Institute (NHLBI) Gene Therapy Resource Program (GTRP). This paper reviews the core components of the GTRP and describes how the GTRP provides researchers with resources that are critical to advancing investigational gene therapy products into clinical testing.
Get full access to this article
View all access options for this article.
References
1.
BergP., BaltimoreD., BrennerS.et al.1975. Summary statement of the Asilomar Conference on Recombinant DNA Molecules. Proc. Natl. Acad. Sci. U.S.A., 72:1981–1984.
2.
CollinsF.S.2010. Research agenda: Opportunities for research and NIH. Science, 327:36–37.
3.
CollinsF.S.2011. Reengineering translational science: The time is right. Sci. Transl. Med., 3:90cm17.
